These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33417081)

  • 41. Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer.
    Yamashita H; Sun CC
    Pharm Res; 2019 Apr; 36(6):90. PubMed ID: 31016440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
    Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
    Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Compressed mini-tablets as a biphasic delivery system.
    Lopes CM; Lobo JM; Pinto JF; Costa P
    Int J Pharm; 2006 Oct; 323(1-2):93-100. PubMed ID: 16828999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent.
    Rao VM; Haslam JL; Stella VJ
    J Pharm Sci; 2001 Jul; 90(7):807-16. PubMed ID: 11458330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K; Langguth P
    Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular safety pharmacology studies in dogs enabled for a poorly soluble molecule using spray-dried dispersion: Impact on lead selection.
    Tseng YC; Linehan B; Ng KJ; Smith DM; Markert M; Patel M; Guth B; Fryer RM
    Int J Pharm; 2016 Oct; 512(1):137-146. PubMed ID: 27543349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and evaluation of dapsone tablets coated for specific colon release.
    Barros PD; Dias IFT; Zanin GD; Bunhak ÉJ
    Drug Dev Ind Pharm; 2020 Feb; 46(2):246-252. PubMed ID: 31951762
    [No Abstract]   [Full Text] [Related]  

  • 48. The Effect of Inorganic Salt on Disintegration of Tablets with High Loading of Amorphous Solid Dispersion Containing Copovidone.
    Xi H; Ren J; Novak JM; Kemp E; Johnson G; Klinzing G; Johnson MA; Xu W
    Pharm Res; 2020 Mar; 37(4):70. PubMed ID: 32185516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.
    Wlodarski K; Tajber L; Sawicki W
    Eur J Pharm Biopharm; 2016 Dec; 109():14-23. PubMed ID: 27658987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of excipients and curing process on the abuse deterrent properties of directly compressed tablets.
    Rahman Z; Zidan AS; Korang-Yeboah M; Yang Y; Siddiqui A; Shakleya D; Khan MA; Cruz C; Ashraf M
    Int J Pharm; 2017 Jan; 517(1-2):303-311. PubMed ID: 27956191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tablet fragmentation without a disintegrant: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets.
    Arafat B; Wojsz M; Isreb A; Forbes RT; Isreb M; Ahmed W; Arafat T; Alhnan MA
    Eur J Pharm Sci; 2018 Jun; 118():191-199. PubMed ID: 29559404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers.
    Reddy AB; Reddy ND
    Drug Res (Stuttg); 2017 Jul; 67(7):412-418. PubMed ID: 28449156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of tablet solubility and hygroscopicity on disintegrant efficiency in direct compression tablets in terms of dissolution.
    Gordon MS; Chowhan ZT
    J Pharm Sci; 1987 Dec; 76(12):907-9. PubMed ID: 3440935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of In Vitro-In Vivo Correlation for Amorphous Solid Dispersion Immediate-Release Suvorexant Tablets and Application to Clinically Relevant Dissolution Specifications and In-Process Controls.
    Kesisoglou F; Hermans A; Neu C; Yee KL; Palcza J; Miller J
    J Pharm Sci; 2015 Sep; 104(9):2913-22. PubMed ID: 25611455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling.
    Li J; Chai H; Li Y; Chai X; Zhao Y; Zhao Y; Tao T; Xiang X
    PLoS One; 2016; 11(8):e0160260. PubMed ID: 27479702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M; Bećirević-Laćan M
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Injection moulded controlled release amorphous solid dispersions: Synchronized drug and polymer release for robust performance.
    Deshmukh S; Paradkar A; Abrahmsén-Alami S; Govender R; Viridén A; Winge F; Matic H; Booth J; Kelly A
    Int J Pharm; 2020 Feb; 575():118908. PubMed ID: 31809859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benznidazole Extended-Release Tablets for Improved Treatment of Chagas Disease: Preclinical Pharmacokinetic Study.
    Davanço MG; Campos ML; Rosa TA; Padilha EC; Alzate AH; Rolim LA; Rolim-Neto PJ; Peccinini RG
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2492-8. PubMed ID: 26883698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.